2025’s Biggest Shift in Orphan Drugs: Months-Not-Years Access to Greater China October 2, 2025 / Overview / Mike Zhou 2025’s Biggest Shift in Orphan Drugs: Months-Not-Years Access to Greater China Read More »
KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market September 12, 2025 / Press / Mike Zhou KYBORA and ACA Pharma Partner to Accelerate Access to China’s Life Sciences Market Read More »
Named Patient Program Overview for China July 28, 2025 / Overview / Mike Zhou Named Patient Program Overview for China Read More »
Deflazacort Launch in China via Macau Fast-Track Pathway July 14, 2025 / Case Studies / Mike Zhou Deflazacort Launch in China via Macau Fast-Track Pathway Read More »
